Afstyla recombinant and Lenvatinib Mesylate
Determining the interaction of Afstyla recombinant and Lenvatinib Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Afstyla (recombinant)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Afstyla recombinant-Lenvima
- Afstyla recombinant-Lenvima (14 MG Daily Dose)
- Afstyla recombinant-Lenvima (18 MG Daily Dose)
- Afstyla recombinant-Lenvima (20 MG Daily Dose)
- Afstyla recombinant-Lenvima (24 MG Daily Dose)
- Afstyla recombinant-Lenvima (8 MG Daily Dose)
- Lenvatinib Mesylate-Aftera
- Lenvatinib Mesylate-Aftertest Topical Pain Relief
- Lenvatinib Mesylate-Agalsidase beta
- Lenvatinib Mesylate-Agalsidase beta Intravenous
- Lenvatinib Mesylate-Agenerase
- Lenvatinib Mesylate-Aggrastat